Bioasis Technologies Cash Flow - Quarterly (OTCMKTS:BIOAF)

Add to My Stocks
$0.31 $0.01 (3.13%) BIOAF stock closing price Sep 18, 2018 (Closing)

The financial analysis of BIOAF requires an investor to check the cash flows for Bioasis Technologies. While its important to look at the Bioasis Technologies debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Bioasis Technologies revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. This statement can tell if a company is running out of money while still being profitable and is useful in Bioasis Technologies stock analysis. Bioasis Technologies had a negative net income cash flow of $-2.25M till this quarter of 2018 Q3. This report is very useful in measuring the short term viability of a company. The cash from operating activities for Bioasis Technologies is $ 2018 Q3, which saw a decrease from previous quarter.

View and download details of Bioasis Technologies cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Mar - Feb2018 Q32018 Q22018 Q12017 Q42017 Q12016 Q4
Net Income Cash Flow
-2.25M-1.27M-0.39M-2.28M-0.69M-1.97M
Depreciation Depletion Amortization Cash-Flow------
Net Increase (Decrease) in Assets Liabilities-0.36M-0.53M-0.26M---
Cash From (used in) Discontinued Operations------
Other Adjustments Net---1.11M--
Net Cash from (used by) Operating Activities
-1.86M-1.35M-0.5M-0.94M-0.19M-1.17M
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.01M----
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments-0.05M-----0.42M
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
-0.07M-0.01M----0.42M
Issuance (Purchase) of Equity Shares3.05M2.9M2.81M--1.16M
Issuance (Repayment) of Debt Securities------
Increase (Decrease) in Bank & Other Borrowings------
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities------
Net Cash from (used by) Financing Activities
3.05M2.9M2.81M--1.16M
Effect of Exchange Rate Changes on Cash------
Net Change in Cash & Cash Equivalents
1.1M1.54M2.31M-0.16M--0.43M
Cash & Equivalents at Beginning of Year1.02M-1.62M1.04M--
Cash & Equivalents at Year End1.54M1.97M2.72M-1.05M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Ascendis Pharma financial analysis

Bioasis Technologies stock price history provides insight into historical stock price fluctuations, and Bioasis Technologies stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Bioasis Technologies had a Net Change in Cash and Cash Equivalents of $1.1M in the latest quarter 2018 Q3. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Bioasis Technologies stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Bioasis Technologies decreased its cash from operating activities to $-1.86M till 2018 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.07M for BIOAF stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $3.05M for Bioasis Technologies. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Bioasis Technologies Cash Flow

FCF margin
0